Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotarix Long-term Efficacy and Safety (3 Years Post-Vaccination)
NCT00420316Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2007
- Primary completion
- Aug 2007
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral in rotavirus infection, sponsored by GSK. Started Feb 2007; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00420316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00420316.